Search

everythinglearnresearchcommunity

for

Search:↓

Rice bran extract and low-frequency electromagnetic fields together may help treat vitiligo and white hair.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Severe digestive issues in DRESS need early endoscopy for better treatment.

Red ginseng extract (GS-E3D) may promote hair growth and has antioxidant and anti-inflammatory properties.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

Eclipta prostrata helps hair growth and maintains the growth phase by affecting certain growth factors.

EBF1 controls hair type and length.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Retinoic acid affects skin and hair health by working with specific receptors, and its absence can lead to hair loss and skin changes.

A protein called FERONIA helps control root hair growth in response to cold and low nitrogen by activating nutrient-sensing pathways in a plant called Arabidopsis.

BMS-470539 reduces skin fibrosis and inflammation.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Cyclic ADP-ribose helps regulate calcium and signals that promote hair growth in hair follicle cells.

A new EDA gene variant causes X-linked hypohidrotic ectodermal dysplasia in a Chinese family.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

Pro-Ile could be used in cosmetics to improve skin, hair growth, and healing.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

A new hair loss treatment combining minoxidil and cedrol improves hair growth and reduces side effects.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.